AptarGroup, Inc. with ticker code (ATR) now have 5 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $174.00 and $135.00 suggesting an average Analsyt target price of $160.40. Given that the stocks previous close was at $158.94 and the analysts are correct then there would likely be a percentage uptick in value of .9%. It’s also worth noting that there is a 50 day moving average of $150.55 while the 200 day moving average is $142.33. The total market capitalization for the company now stands at 10.68B. The price for the stock stands currently at: $160.89 USD
The potential market cap would be $10,779,345,550 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 33.87, revenue per share of $53.91 and a 6.88% return on assets.
AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma includes operations that sells dispensing systems and sealing solutions and also manufactures and sells elastomeric primary packaging components. The Company’s products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Aptar Beauty segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. The Aptar Closures business serves multiple markets, including food, beverage, personal care, home care, beauty and healthcare. This segment offers food protection business and elastomeric flow-control technology business.
